Starpharma Holdings Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2016
Operating Revenue	4.91	8.29	4.21	4.9	2.15	Upgrade
Other Revenue	0.94	1.47	0.14	0.26	1.34	Upgrade
Revenue	5.85	9.76	4.34	5.16	3.49	Upgrade
Revenue Growth (YoY)	-40.04%	124.64%	-15.87%	48.04%	-50.99%	Upgrade
Cost of Revenue	9.58	10.69	12.36	14.46	15.87	Upgrade
Gross Profit	-3.73	-0.93	-8.02	-9.29	-12.38	Upgrade
Selling, General & Admin	6.26	7.24	7.62	6.86	7.35	Upgrade
Operating Expenses	6.26	7.24	7.62	6.86	7.35	Upgrade
Operating Income	-9.99	-8.17	-15.64	-16.15	-19.73	Upgrade
Pretax Income	-9.99	-8.17	-15.64	-16.15	-19.73	Upgrade
Earnings From Continuing Operations	-9.99	-8.17	-15.64	-16.15	-19.73	Upgrade
Net Income	-9.99	-8.17	-15.64	-16.15	-19.73	Upgrade
Net Income to Common	-9.99	-8.17	-15.64	-16.15	-19.73	Upgrade
Shares Outstanding (Basic)	417	411	409	407	397	Upgrade
Shares Outstanding (Diluted)	417	411	409	407	397	Upgrade
Shares Change (YoY)	1.40%	0.59%	0.53%	2.53%	6.62%	Upgrade
EPS (Basic)	-0.02	-0.02	-0.04	-0.04	-0.05	Upgrade
EPS (Diluted)	-0.02	-0.02	-0.04	-0.04	-0.05	Upgrade
Free Cash Flow	-6.8	-7.07	-14.93	-14	-15.05	Upgrade
Free Cash Flow Per Share	-0.02	-0.02	-0.04	-0.03	-0.04	Upgrade
Gross Margin	-63.74%	-9.52%	-184.57%	-180.05%	-	Upgrade
Operating Margin	-170.77%	-83.69%	-360.07%	-312.94%	-565.87%	Upgrade
Profit Margin	-170.77%	-83.69%	-360.07%	-312.94%	-565.87%	Upgrade
Free Cash Flow Margin	-116.26%	-72.43%	-343.82%	-271.19%	-431.72%	Upgrade
EBITDA	-9.72	-7.85	-15.25	-15.8	-19.43	Upgrade
EBITDA Margin	-166.21%	-80.45%	-	-	-	Upgrade
D&A For EBITDA	0.27	0.32	0.39	0.36	0.3	Upgrade
EBIT	-9.99	-8.17	-15.64	-16.15	-19.73	Upgrade
EBIT Margin	-170.77%	-83.69%	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.